Objective: To determine when energy expenditure becomes elevated in infants with cystic fibrosis (CF). Design: Longitudinal studies of total energy expenditure (TEE) using doubly labeled water were conducted in infants identified with CF by newborn screening through the first year of life. Setting: Hospital and community based studies in Denver, Colorado, USA and Cambridge, UK. Results: Eight of the 12 infants enrolled had begun enzyme therapy but were clinically asymptomatic. Four of the 12 infants were heterozygous for the delta F508 mutation, however no difference was seen in TEE from the remaining homozygous infants. TEE was compared to control cohorts at 2, 6 and 12 months of age. There was no difference from the control groups in TEE=kg fat free mass (FFM)=day at 2 months. However, by 6 months of age TEE=kg FFM=day in infants with CF exceeded that of agematched controls by 25% (P < 0.001). This elevation in TEE continued at 12 months of age exceeding that of controls by 30% (P < 0.05). Conclusions: These results indicate that infants with CF have increased energy needs by 6 months of age and that early diagnosis alone does not prevent the development of increased caloric requirements. These findings emphasize the need for close nutritional monitoring to prevent suboptimal growth during infancy in this population.
Introduction
Potential disturbances in energy metabolism and energy balance in cystic fibrosis (CF) has been of interest for many years. During the past decade, for example, there has been a number of studies undertaken to determine both the resting and total energy expenditure (TEE) of patients with CF. Early studies of children, adolescents and young adults with CF have established that daily energy needs are higher due to an increase in both these measures of energy expenditure (Pencharz et al, 1984; Vaisman et al, 1987; Buchdahl et al, 1988) . Failure to meet these increased energy needs through energy intake has been suggested as a primary reason why children with CF often display chronic growth retardation and malnutrition (Parsons et al, 1983; Pencharz 1983; Soutter et al, 1986; Bronstein et al, 1992) . Malnutrition also plays a role in the progressive lung disease that characterizes CF, although the mechanisms are not fully defined. Poor growth, a marker of malnutrition (Lai et al, 1998) , has been associated with an increased morbidity and mortality rate for patients with CF (Kraemer et al, 1978; Erdman, 1999; Turck & Michaud, 1998) .
There are now much data to show that resting energy expenditure (REE) is elevated in CF (Buchdahl et al, 1988; Parsons et al, 1983; Fried et al, 1991; O'Rawe et al, 1992; Spicher et al, 1991; Steinkamp et al, 1993; Grunow et al, 1993; Tomezko et al, 1994; Horswill et al, 1994; Bell et al, 1996; Zemel et al, 1996) . Controversy exists, however, with regard to the factors responsible and whether an increased TEE is a consistent observation among individuals with CF. Suggested factors contributing to an increased REE include the presence of pulmonary disease, respiratory infection, catchup growth and possibly a basic energy-consuming cellular defect or subclinical manifestation of CF (Feigel et al, 1979; Thomas et al, 1991) . Recent evidence does not consistently support or fully explain an association of decreased pulmonary function or pulmonary infection with increased REE (Bell et al, 1996; Zemel et al, 1996; Stallings et al, 1998; Thomson et al, 1996) . Correlations between levels of REE and genotype and pancreatic phenotypes have been reported (Tomezko et al, 1994; Thomson et al, 1996) however the numbers of pancreatic sufficient subjects with CF and heterozygous genotypes have been small. These investigations have measured REE primarily by indirect calorimetry and there are few reports of measurement of TEE in children and young adults with CF, which will primarily determine energy requirements.
Similarly, there are even fewer data relating to REE or TEE in infants with CF. Identifying infants by newborn screening provides the opportunity for measurements to be made with the absence of clinical symptoms of disease which are considered as factors that may raise TEE and hence energy requirements. It is important to consider TEE of presymptomatic infants with CF for several reasons. Reported early growth failure during the first months of life (Bronstein et al, 1992; Farrell et al, 1997) may be corrected or even prevented by providing adequate nutrition. Results of cross-sectional studies of infants with CF have been conflicting as to whether TEE is elevated in the absence of clinical symptoms and there have been no longitudinal studies of the pattern of energy requirements in this population. Shepherd and colleagues (Shepherd et al, 1988) were the first to report elevated TEE using the doubly labeled water technique in infants and young children with CF (ie 2.0 y old) identified through newborn screening. This study of nine subjects which reportedly controlled for clinical symptoms of disease and weight found the mean TEE to be 25% higher than ageand weight-matched controls when expressed as kJ per kg of body weight. Similarly, Girardet et al, 1994 reported REE expressed as kj per kg of fat free mass (FFM) to be 26% above that of control infants between 2 -7 months of age. Thomson et al, 1995 found REE=kg body weight and per kg of body cell mass to be elevated (by 23 and 15%, respectively) in nine infants (0.41 AE 0.30 y) homozygous for CF. Interestingly, in contrast with these findings, Bronstein et al, 1995 found no difference in the TEE of infants 0.8 -6.6 months of age when expressed as kJ=kg FFM compared with normal controls. The method of measuring energy expenditure, definitions of asymptomatic and the relatively wide range of ages of the infants studied make it difficult to discern whether a true elevation in energy expenditure occurs in all infants with CF, and when this elevation occurs in early life.
The objective of this study, therefore, was to longitudinally measured TEE in presymptomatic infants with CF at specified ages to determine if, and when, energy requirements were greater than those of infants without CF. We also attempted to assess the role of body composition, markers of disease progression and TEE on apparent energy deficits that negatively affect growth during the first year of life.
Subjects and methods

Subjects
The subjects were infants identified by statewide newborn screening for CF in Colorado, USA. Diagnosis was determined by sweat testing. Parents of all newly diagnosed infants were notified of the study and invited to participate. Selection criteria included that the infant be 3 months of age at the time of enrollment, asymptomatic for lung disease, free of respiratory infection and hence not using bronchodilators or antibiotic therapy prior to the first study period. Infants who were small for gestational age or who experienced meconium ileus were excluded. Prior to acceptance into the study all infants were assessed clinically and by physical examination. Consent forms approved by the Internal Review Board of the University of Colorado Health Sciences Center were signed by parents at the time of enrollment.
Subjects were admitted to the General Clinical Research Center (CRC) of The Children's Hospital, Denver, Colorado as soon as possible after diagnosis and typed for the presence of the delta F508 mutation using the method of Kerem et al, 1989 as modified by Rommens et al, 1989 . Screening for 12 specific deletions took place. Further health assessments included a chest X-ray, nasal wash for viral cultures, throat culture for bacteriological studies, white blood cell count, erythrocyte sedimentation rate, C-reactive protein and albumin. Oxygen saturation measurement was performed using the Nellcor pulse oximeter (Hayward, CA, USA).
Study design
Subjects were studied at 2, 6 and 12 months of age while admitted to the CRC. During each admission nutrient balance studies, determination of TEE and lean body mass by doubly labeled water were conducted. Length to the nearest 0.1 cm and daily weights to the nearest 1.0 g were determined using a stadiometer (Holtain Limited, UK) and Sartorius scale (Sartorius AG, Gottingen, Germany), respectively. For the nutrient balance studies, total dietary intake was measured over a 72 h period. This was accomplished by weighing breast fed infants before and after feeding on the Sartorius scale and for bottle-fed infants, by weighing the bottle before and after feeding. Dishes with foods were weighed before and after each feeding to obtain actual intake to the closest 0.1 g. Literature values were used for Longitudinal investigation of energy in CF PSW Davies et al gross breast milk composition (Fomon, 1974) and manufacturer's reported values were used for formula and food composition. The first meal of the balance study period contained 10 ml of water with added methylene blue. This non-absorbable marker allowed the 72 h of the balance to be accurately determined. When the first blue marker was observed in the feces collection began for balance studies to determine the coefficient of fat absorption. A second blue marker was administrated 72 h later and fecal collection stopped when the marker appeared in the feces. Weighed plastic bags were used as diaper liners to collect stools. Stools were analyzed for fecal fat by a modified method of Van der Kamer et al, 1949 . The coefficient of excretion for fat was calculated as fecal fat=dietary fat intakeÂ100.
Doubly labeled water technique TEE was measured using the doubly labeled ( 2 H 2 18 O) water isotope procedure previously utilized for studying infants as described by Davies et al, 1989 . Validation studies performed in infants have shown this method of measuring TEE to have an accuracy of 1 to 2% and a precision of 3 to 6% when compared to near continuous indirect calorimetry over a 5 to 6 day period (Jones et al, 1987 (Jones et al, , 1988 . The protocol used in this present study is based on those used in previous studies validating the doubly labeled water technique in infants (Jones et al, 1987; Roberts et al, 1986; Jensen et al, 1992) . Two samples of urine were obtained from each infant prior to administration of the stable isotopes for assessment of naturally occurring levels of 2 H and 18 O. The source of oral water intake was maintained constant for at least 1 week prior to and for the duration of each study period. Administration of the isotopes took place on the first day of each inpatient stay time between feedings to ensure optimum absorption and equilibration. Balance studies ran simultaneously with energy expenditure studies. Each infant received an oral dose of approximately 0.10 g 2 H 2 O (99.996% enriched) and 0.30 g H 2 18 O (97% enriched) per kg body weight. The dose was decreased to 0.05 g and 0.15 g per kg of body weight of each isotope, respectively at 1 y of age. After 5 h post dose to allow for equilibrium, a urine sample was collected using a U-bag (Hollister Inc., Libertyville, IL, USA). These bags are gently adhered to the infant in such a way that allows collection of urine easily, and prevents mixing of the urine and feces. Beginning with the morning following the isotope administration, daily urine samples were collected for the next 7 days with the time of the sample collection being recorded. This 7 day period represents 2 to 3 biological half-lives of the isotopes in the body determined by water turnover (Fjeld et al 1989; Roberts et al, 1988) . The urine samples were analyzed for isotopic enrichment relative to local standard by isotope-ratio mass spectrometry (Aqua-Sira model; VG Isogas, Cheshire, UK). Isotopic elimination rates of 2 H and 18 O were calculated from the logarithmic regression of the eight data points, after correcting for pre-dose background levels. The 2 H and
18
O dilution spaces were individually determined from the zero time intercept of the respective regressions. Changes in the size of the dilution spaces over the course of the metabolic period were taken into account (Roberts et al, 1986; Wells et al, 1998) . To adjust for fractionation, evaporative losses were estimated using the approach of Jones et al, 1988 . To estimate the caloric equivalent of each liter of CO 2 produced comparative to the control population, a respiratory quotient (RQ) of 0.85 was assumed and TEE was calculated using the Weir (Weir, 1949) equation. The RQ varies with age and 0.85 has been determined to be appropriate for infants based on calculation from food quotients in previous validation studies (Black et al, 1986; Davies et al, , 1997 .
Assuming that body fat is anhydrous, and the hydration of the FFM is known and constant, body composition ie the amount of FFM and fat mass in the body can be calculated from measurements of total body water. In this study total body water was determined from the 18 O dilution space. In order to take into account the overestimation of true total body water by the use of 18 O the dilution space was reduced by 1% to determine total body water. This overestimation is due to the exchange of 18 O with non aqueous oxygen in the body (Schoeller, 1983) . Published values of hydration of the FFM (Fomon et al, 1982) were used to convert total body water to FMM.
Body weight was expressed as a Z score calculated using the National Center for Health Statistics database (Hamill et al, 1979) .
TEE and body composition data from control infants in the UK were obtained using methods identical to those described above. The control population consists of data from cross-sectional studies at each age of the study (Davies et al, 1989 (Davies et al, , 1997 Statistical methods Data was analyzed using SAS (Cary, NC, USA). Differences between the CF and control populations were evaluated at each age point by unpaired t-tests for TEE and FFM. TEE for the infants with CF was analyzed longitudinally by ANOVA using methods of Laird and Ware, 1986 and Liang and Zeger, 1986 via Proc Mixed (SAS) to allow for missing data and uneven time points of data collection.
Results
A total of 12 infants (eight female) with CF were enrolled in the study. The mean ( AE s.d.) age at the first study period was 2.1 AE 0.8 months. Details relating to genotype, age of first measurement, weight, weight of FFM and percentage fat absorption are shown in Table 1 . One subject was born 10 weeks premature and was studied at her adjusted ages. The fecal fat collection for one subject was incomplete at 2 months of age and therefore not included in the data set. The mean coefficient of fat absorption during the first study Longitudinal investigation of energy in CF PSW Davies et al period was 79 AE 18%. Eight infants had begun enzyme replacement therapy prior to the study based on symptoms but were otherwise clinically asymptomatic. Nasal wash for viral cultures, throat cultures for bacterial studies, while cell count, erythrocyte sedimentation rate and C-reactive protein measurements revealed the following findings. On eight occurances subjects tested positive for Pseudamonus A, Staph. A or H. Influezae during their first year of life. These consist of one positive test at 1 month of age, one positive test at 2 months of age, two positive tests at 3 months of age, and two further positive tests at 6 months of age and 12 months of age. Nevertheless, importantly, none of the infants showed symptoms that would have been identified in the clinical setting as having respiratory problems except for one infant at 6 months of age who is discussed later. Only three infants had raised erythrocyte sedimentation rate throughout the study period. All these being at 1 y of age. All subjects were within normal range for C-reactive protein measurements, white blood cells (WBC) was elevated in all but two assessments. It is worth reiterating that despite these findings none showed symptoms of respiratory problems. At the 6 months old study period all infants were using enzyme replacement therapy and by 1 y of age one infant had discontinued enzyme replacement therapy based on fecal fat study data. Seven of the 12 infants were studied at all of the three study periods. Three subjects withdrew from the study due to the inconvenience of the inpatient stay. Urine samples were not adequate for analysis in a further two infants at the 2 month study period and for one infant at the 6 month study period. The mean ( AE s.d.) age, weight, weight Z score, FFM and coefficient of fat absorption for the 6 and 12 month old studies, as well as those at recruitment are indicated in Table 2. TEE is expressed for each study age as kJ=day, kJ=kg body weight=day and kJ=kg FFM=day. For comparison purposes, Z scores are also given in the table. There was no significant difference in TEE expressed as kJ=kg body weight=day (P ¼ 0.07) or as kJ=kg FFM=day (P ¼ 0.16) at 2 months of age between the infants with CF and controls. However, by 6 months of age the TEE in infants with CF exceeded that of the controls by 32% (P < 0.01) when expressed as kJ=kg body weight or by 20% when expressed per kg FFM (P < 0.001). At 1 y of age TEE in infants with CF (564 ¼ 113 kJ=kg FFM=day) continued to be elevated by 19% over that of controls (475 -97 kJ=kg FFM=day), P < 0.05. When expressed as kJ=kg body weight=day the TEE of infants with CF was 28% greater than that of the controls, P < 0.004 (see Figure 1) .
Four of the 12 infants were heterozygous for the delta F508 mutation however no difference was seen in TEE from the remaining homozygous infants. There was no relationship between coefficient of fat absorption and weight-for-age Z score or between energy intake and energy expenditure per kg. Similarly, energy expenditure was not related to weightfor-age Z score. 
þ denotes F508 mutation. -denotes second deletion not specified Table 2 The mean and standard demotion of the age, weight, weight Z score, and fat free mass in the infants with cystic fibrosis and the controls. Data relating to percentage fat absorption is given for the infants with CF only. 
Discussion
TEE in a group of 12 infants with CF was compared to control data at 2, 6 and 12 months of age. In agreement with previous work (Bronstein et al, 1995) there was no difference between the two groups at 2 months of age, however by 6 months of age TEE per kg of body weight and per kg of FFM exceeded that of controls by approximately 32 and 20%, respectively. This elevation of TEE continued at 12 months of age. It should be noted however that one infant at 6 months of age had been admitted to hospital for pneumonia. As might therefore be expected the energy expenditure of this infant was high. Nevertheless the removal of this data from the analysis only reduces the mean energy expenditure in kJ=kg FFM by 3% to 525 kJ=kg FFM per day, and the mean Z score of TEE is reduced from 1.37 to 1.16. These values are still significantly elevated relative to the normal controls. In other studies of TEE in cohorts of infants with CF (ages ranging from 1 to 24 months old) in the literature (Thomson et al, 1996 (Thomson et al, , 1995 Girardet et al, 1994) , the average, energy expenditure was elevated by 25% over controls when expressed per kg of body weight in these cross-sectional investigations. Energy expenditure in infants with CF is elevated even when body cell mass (BCM) or FFM is considered. Energy expenditure is best expressed per unit of BCM or FFM which represents metabolically active tissue (Thomson et al, 1995) . A confounding factor of using FFM rather than BCM that may effect the precision of energy expenditure calculations is that the hydration of FFM may vary during infancy. These potential discrepancies have been determined to be minimal at best (Wells et al, 1988; . However, attention must be given to how energy expenditure is expressed for this study population due to possible differences in overall growth and body composition (Greer et al, 1991) .
The use of the doubly labeled water technique in infants has been used extensively to develop the large database of the control population utilized in the present study. This technique offers the advantage of non-invasively measuring TEE over a week-long period of time and allowing conditions of free-living activities. The infants with CF were studied in a clinical setting while the control infants were studied in their home environments. Care was given not to interfere with normal physical activity in both situations. If differences in physical activity did exist, one would assume that it would be greater in the home environment which only increases the validity of the conclusion that infants with CF have elevated TEE.
Several factors have been proposed to explain why energy expenditure is elevated during infancy. Elevated REE has Figure 1 Mean and standard error of mean of the energy expenditure of the infant with cystic fibrosis and controls exposed as kJ=kg fat free mass at 2, 6 and 12 months of age. 
Longitudinal investigation of energy in CF PSW Davies et al been reported for groups of children homozygous for the delta F508 mutation (O'Rawe et al, 1992; Tomezko et al, 1994) . It must be noted that the energy requirements of these older children may have been affected by differences in the severity of disease associated with genotype. Thomson and colleagues, (Thomson et al, 1995) reported elevated REE for young children 2 y of age with CF who were homozygous for the delta F508 mutation and for those with pancreatic insufficiency, however this was not the case for heterozygous children or those with pancreatic sufficiency. Four of the 12 CF infants in the current study were heterozygous for the delta F508 mutation, one of which produced a pancreatic sufficient phenotype. No apparent differences were noted in TEE of these infants at any age however the sample size was small. Further investigation is required to define an independent effect of genotype on energy expenditure.
By studying infants identified through neonatal screening rather than by diagnosis following the onset of symptoms, any effects of declining pulmonary function or infection on TEE can be minimized. In all reports of energy expenditure in CF infants including the present study all subjects were reported to be 'clinically stable'. It has been frequently detected by our clinic that while infants appear to be clinically well, pulmonary inflammations and elevated levels of cytokines are present (Kahn et al, 1995) . Thomson et al, 1996 conducted bronchoscopies in a subset of his study group however no effect of markers of lung inflammation on energy expenditure was seen. If these subclinical markers do raise energy needs one would expect to see elevated levels of TEE even at 2 months of age which was not the case. It is possible that there is a threshold effect that is not measurable until closer to 6 months of age. This requires further investigation due to the small numbers of very young infants studied. The possibility of a previously proposed basic cellular defect driving energy expenditure up is viable if one considers a threshold effect that becomes amplified with age during the first 6 months of life. Increased physical activity in CF infants is not a likely reason for elevated TEE.
The occurrence and severity of pancreatic insufficiency is variable during the first year of life (Bronstein et al, 1992) . Consistent with the current findings, pancreatic insufficiency appears to be a major contributor to poor growth during the first few months of life in screened infants positive for CF. In agreement with Thomson et al, 1995 it does not appear that young infants are able to compensate for elevated energy needs by spontaneously increasing intake and=or decreasing physical activity. Shepherd reported that catch-up growth, may account for elevated TEE during the 6 -12 month period, although the energy costs of growth that would be measured in TEE is very small.
In conclusion, a longitudinal study of clinically well infants with CF indicates that energy expenditure is comparable to that of infants without CF at 2 months of age, becomes elevated by 6 months of age and this pattern continues through the first year of life. These findings emphasize the need for close nutritional monitoring and nutritional prescription to prevent malnutrition and subopitimal growth during infancy in this population.
